Your browser does not support JavaScript capabilities, which maybe required to display this page properly.


PDF FormatRequires Adobe Acrobat Reader

Table 12.14

Unadjusted Patient Survival, Deceased Donor Lung Transplants

Survival at 3 Months, 1 Year, 5 Years, and 10 Years

  3 Months 1 Year 5 Years 10 Years
(Tx 2006 - 2007) (Tx 2006 - 2007) (Tx 2002 - 2007) (Tx 1997 - 2007)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 2,718 92.3% 0.5% 2,718 83.3% 0.7% 7,199 54.4% 0.8% 11,661 28.7% 0.8%
Lung Diagnosis Group Group A: Obstructive Lung Disease 1,048 93.9% 0.7% 1,048 85.5% 1.1% 3,209 55.5% 1.1% 5,698 25.5% 1.0%
Group B: Pulmonary Vascular Disease 91 87.9% 3.4% 91 80.2% 4.2% 281 54.7% 3.8% 519 35.4% 3.0%
Group C: Cystic Fibrosis or Immunodef. Disorders 398 94.7% 1.1% 398 86.7% 1.7% 1,074 57.3% 2.0% 1,778 38.0% 1.8%
Group D: Restrictive Lung Disease 1,123 90.5% 0.9% 1,123 80.1% 1.2% 2,479 51.1% 1.5% 3,364 27.5% 1.7%
Group E: Age Less Than 12 38 89.5% 5.0% 38 84.2% 5.9% 99 60.3% 6.4% 192 38.9% 5.0%
Other Diagnosis 20 95.0% 4.9% 20 95.0% 4.9% 57 70.1% 7.2% 110 31.2% 8.8%


Source: OPTN/SRTR Data as of May 4, 2009.

(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Patient survival follows patients from first transplant of this type until death. Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on lung and heart-lung transplants.

Multi-organ transplants are excluded.



PDF FormatRequires Adobe Acrobat Reader